| 讲座 |
|
|
|
|
| 细胞药物的研发现状——细胞药物连载之三 |
| 王佃亮1, 杜娟2 |
1 中国人民解放军火箭军总医院药学部组织工程与再生医学实验室 北京 100088;
2 中国人民解放军火箭军总医院医务部 北京 100088 |
|
| The Current Research and Development Status of Cell Drug |
| WANG Dian-liang1, DU Juan2 |
1 Tissue Engineering and Regenerative Medicine Laboratory, The General Hospital of The PLA Rocket Force, Beijing 100088, China;
2 Medical Affairs Department, The General Hospital of The PLA Rocket Force, Beijing 100088, China |
| [1] Peng Y.The patentability of human embryonic stem cell technology in China. Nat Biotechnol,2016,34(1):37-39.
[2] Plaza Reyes A, Petrus-Reurer S, Antonsson L, et al. Xeno-free and defined human embryonic stem cell-derived retinal pigment epithelial cells functionally integrate in a large-eyed preclinical model.Stem Cell Reports,2016,6(1):9-17.
[3] Sugarman J. Human stem cell ethics:beyond the embryo. Cell Stem Cell, 2008,2(6):529-533.
[4] Tartarini D, Mele E. Adult stem cell therapies for wound healing:biomaterials and computational models.Front Bioeng Biotechnol,2016,3:206.
[5] Clevers H. What is an adult stem cell.Science, 2015,350(6266):1319-1320.
[6] Devitt S M, Carter C M, Dierov R, et al.Successful isolation of viable adipose-derived stem cells from human adipose tissue subject to long-term cryopreservation:positive implications for adult stem cell-based therapeutics in patients of advanced age.Stem Cells Int,2015,2015:146421.
[7] Branch M J, Yu W Y, Sheridan C, et al.Isolation of adult stem cell populations from the human cornea.Methods Mol Biol,2015,1235:165-177.
[8] Park B W.Dental tissues as adult stem cell source. J Korean Assoc Oral Maxillofac Surg,2013,39(2):41-42.
[9] Martinez-Schlurmann N I, Rampa S, Speicher D G, et al.Prevalence, predictors and outcomes of cardiopulmonary resuscitation in hospitalized adult stem cell transplant recipients in the United States:not just opening the black box but exploring an opportunity to optimize.Bone Marrow Transplant,2015,50(12):1578-1581.
[10] Fukada S, Ma Y, Uezumi A. Adult stem cell and mesenchymal progenitor theories of aging.Front Cell Dev Biol,2014,2:10.
[11] Trainor N, Pietak A, Smith T. Rethinking clinical delivery of adult stem cell therapies.Nat Biotechnol,2014,32(8):729-735.
[12] Erbey F, Atay D, Akcay A, et al.Mesenchymal stem cell treatment for steroid refractory graft-versus-host disease in children:A Pilot and First Study from Turkey.Stem Cells Int,2016,2016:1641402.
[13] Aras Y, Sabanci P A, Kabatas S, et al. The effects of adipose tissue-derived mesenchymal stem cell transplantation during the acute and subacute phases following spinal cord injury.Turk Neurosurg,2016,26(1):127-139.
[14] Wang L, Zhang Y, Li H, et al.Clinical observation of employment of umbilical cord derived mesenchymal stem cell for juvenile idiopathic arthritis therapy.Stem Cells Int,2016,2016:9165267.
[15] Pati S, Muthuraju S, Hadi R A, et al.Neurogenic plasticity of mesenchymal stem cell, an alluring cellular replacement for traumatic brain injury.Curr Stem Cell Res Ther,2016,11(2):149-157.
[16] Rainone V, Martelli C, Ottobrini L, et al. Immunological characterization of whole tumour lysate-loaded dendritic cells for cancer Immunotherapy.PLoS One,2016,11(1):e0146622.
[17] Wei F Q, Sun W, Wong T S, et al. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens:evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination.J Exp Clin Cancer Res, 2016,35(1):18.
[18] Wei X C, Yang D D, Han X R, et al. Bioactivity of umbilical cord blood dendritic cells and anti-leukemia effect.Int J Clin Exp Med, 2015,8(10):19725-19730.
[19] Chen Y, Lin J, Guo Z Q, et al.MHC I-related chain a expression in gastric carcinoma and the efficacy of immunotherapy with cytokine-induced killer cells. Am J Cancer Res,2015,5(10):3221-3230.
[20] Wang Y, Xu Z, Zhou F, et al. The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors. Exp Hematol Oncol,2015,4:32.
[21] Li W, Wang Y, Kellner D B, et al. Efficacy of cytokine-induced killer cells in the treatment of elderly patients with metastatic pancreatic adenocarcinoma.Cent Eur J Immunol,2015,40(2):188-193. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
